Inactive Instrument

Insiders Matinas BioPharma Holdings Inc Other OTC

Equities

US5768101058

End-of-day quote Other OTC Other stock markets
- ^USD	-

Apr. 30	In Vivo Efficacy of Matinas BioPharma?s Oral MAT2203 in Pulmonary Mucormycosis Published in Journal of Antimicrobial Agents and Chemotherapy	CI
Mar. 27	Transcript : Matinas BioPharma Holdings, Inc., 2023 Earnings Call, Mar 27, 2024

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Matinas BioPharma Promotes Eric J. Ende as Chairman of the Board	22-09-21	MT
Matinas BioPharma Holdings, Inc. Announces Board Changes, Effective October 1, 2022	22-09-21	CI
Matinas BioPharma Holdings, Inc. Announces Retirement of Raphael J. Mannino, Chief Scientific Officer, Effective December 31, 2022	22-08-11	CI
Matinas BioPharma Holdings Names Chief Business Officer	21-12-06	MT
Matinas BioPharma Appoints Thomas Hoover, M.B.A. as Chief Business Officer	21-12-06	CI
Matinas BioPharma Holdings, Inc. Elects Kathryn Corzo to the Board of Directors	21-11-01	CI
Matinas Biopharma Holdings, Inc. Announces Resignation of Patrick Le Pore as Director	21-09-17	CI
Matinas BioPharma Holdings, Inc. Announces FDA Conditional Acceptance of LYPDISO™ as the Brand Name for MAT9001	21-01-04	CI
Matinas BioPharma Holdings, Inc. Appoints Hui Liu as Chief Technology Officer	20-12-01	CI
Matinas BioPharma Holdings, Inc. Announces Change of Board of Directors	20-09-14	CI
Matinas Biopharma Holdings, Inc. Appoints James A. Underberg M.D., M.S., Facpm, Facp, Fnyam, Faspc, Fnla to Its Scientific Advisory Board	20-03-04	CI
Matinas Biopharma Holdings, Inc. Appoints James J. Ferguson as Its Chief Medical Officer	19-02-25	CI
Matinas BioPharma Holdings, Inc. Appoints Keith Kucinski as Chief Financial Officer	19-01-03	CI
Matinas BioPharma Appoints Harold E. Bays, M.D. to its Cardiovascular Health Scientific Advisory Board	18-12-19	CI
Matinas BioPharma Holdings, Inc. Establishes A New Scientific Advisory Board	18-12-06	CI
Matinas BioPharma Holdings, Inc. Announces Executive Appointments	18-10-15	CI
Matinas BioPharma Holdings, Inc. Appoints Patrick G. Lepore as Vice Chairman to its Board of Directors	18-09-06	CI
Matinas Biopharma Holdings, Inc. Announces Termination of Dominick M. Dipaolo as Its Senior Vice President of Quality and Regulatory Compliance	18-06-18	CI
Matinas BioPharma Announces Executive Changes	18-03-16	CI
Matinas BioPharma Holdings, Inc. Announces Board Changes, Effective January 1, 2018	17-12-14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Matinas BioPharma Holdings Inc Other OTC

Equities

US5768101058

Insiders

Filters